GTX22074
antibody from GeneTex
Targeting: CXCR4
CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX22074 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX22074, RRID:AB_369470
- Product name
- CXCR4 antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
Submitted references ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.
Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness.
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.
Feng H, Liu Y, Bian X, Zhou F, Liu Y
British journal of cancer 2018 Jan;118(2):224-232
British journal of cancer 2018 Jan;118(2):224-232
Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness.
Zhao Z, Bauer N, Aleksandrowicz E, Yin L, Gladkich J, Gross W, Kaiser J, Hackert T, Strobel O, Herr I
International journal of cancer 2018 Apr 1;142(7):1440-1452
International journal of cancer 2018 Apr 1;142(7):1440-1452
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
Zhang Y, Liu L, Fan P, Bauer N, Gladkich J, Ryschich E, Bazhin AV, Giese NA, Strobel O, Hackert T, Hinz U, Gross W, Fortunato F, Herr I
Oncotarget 2015 Apr 30;6(12):9999-10015
Oncotarget 2015 Apr 30;6(12):9999-10015
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Jin UH, Lee SO, Pfent C, Safe S
BMC cancer 2014 Jul 9;14:498
BMC cancer 2014 Jul 9;14:498
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.
Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I
Oncotarget 2014 Jul 15;5(13):5177-89
Oncotarget 2014 Jul 15;5(13):5177-89
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Western Blot analysis on Hela whole cell lysate using anti-CXCR4 antibody (GTX22074)
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunofluorescence of CXCR4 in HeLa cells with CXCR4 antibody at 20 μg/mL.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunocytochemical staining of HeLa cells with Rabbit anti Human CXCR4 (GTX22074)
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Flow cytometry analysis of HeLa cells using CXCR4 antibody at 0.1 μg/ml. Purple: cells without staining, Green: Isotype control. Red : CXCR4 antibody.